TABLE 1.
Demographic variables of the two study groups
| Variables | Ciprofol (n = 144) | Propofol (n = 145) | P value |
|---|---|---|---|
| Age (mean ± SD, years) | 43.8 ± 11.8 | 44.1 ± 11.3 | 0.929 |
| Sex | 0.364 | ||
| Males, n (%) | 55 (38.2) | 63 (43.4) | |
| Females, n (%) | 89 (61.8) | 82 (56.6) | |
| Height (mean ± SD, cm) | 161.5 ± 8.2 | 163.1 ± 8.4 | 0.103 |
| Weight (mean ± SD, kg) | |||
| Screening | 60.8 ± 9.6 | 62.4 ± 10.0 | 0.193 |
| Baseline | 60.0 ± 9.6 | 61.5 ± 9.7 | 0.212 |
| BMI (mean ± SD, kg/m2) (Screening) | 23.2 ± 2.5 | 23.4 ± 2.6 | 0.671 |
| ASA status, n (%) | 0.744 | ||
| I | 115 (79.9) | 118 (81.4) | |
| II | 29 (20.1) | 27 (18.6) | |
| Modified Mallampati Score, n (%) | 0.904 | ||
| I | 99 (68.8) | 97 (66.9) | |
| II | 43 (29.9) | 45 (31.0) | |
| III | 2 (1.4) | 3 (2.1) |